Insulet
Melanie Littlewood is a seasoned professional in the field of market access and healthcare strategy, currently serving as Senior Director of Value and Access at Insulet International since January 2018. In this role, Melanie has established a robust international value and access function focused on strategic reimbursement and public affairs, committed to enhancing the lives of individuals with diabetes. Previous positions include Director of Value and Access and Head of Market Access at Insulet, as well as significant roles at Eli Lilly and Company, Abbott, and Pfizer, where Melanie has successfully led market access strategies, reimbursement initiatives, and launched major pharmaceutical products. Melanie holds a Bachelor of Science degree in Health from Glasgow Caledonian University.
This person is not in any teams
This person is not in any offices
Insulet
30 followers
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform.